GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » 3-Year FCF Growth Rate

BIO.B (Bio-Rad Laboratories) 3-Year FCF Growth Rate : -22.10% (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories 3-Year FCF Growth Rate?

Bio-Rad Laboratories's Free Cash Flow per Share for the three months ended in Sep. 2024 was $3.57.

During the past 12 months, Bio-Rad Laboratories's average Free Cash Flow per Share Growth Rate was 4.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -22.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Bio-Rad Laboratories was 107.70% per year. The lowest was -63.00% per year. And the median was 3.50% per year.


Competitive Comparison of Bio-Rad Laboratories's 3-Year FCF Growth Rate

For the Medical Devices subindustry, Bio-Rad Laboratories's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's 3-Year FCF Growth Rate falls into.



Bio-Rad Laboratories 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Bio-Rad Laboratories  (NYSE:BIO.B) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Bio-Rad Laboratories 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.